Xilinx CEO Victor Peng has revealed the company has donated more than $1m to organisations fighting the coronavirus pandemic.
On the company’s blog, Peng said: “At Xilinx, we are deeply committed to doing our part in fighting COVID-19. In times of crisis, actions speak louder than words.
“I’m proud to announce that Xilinx has donated $1.1 million for COVID-19 crisis relief. Donations have been made to organizations that are critical to the global effort to combat the pandemic, to our local community in Silicon Valley, and to communities around the world. These include:
- The World Health Organization (WHO) Solidarity Response Fund, which supports the WHO’s amazing global effort, supporting countries to prevent, detect, and respond to the pandemic.
- The University of California San Francisco (UCSF) COVID-19 Response Fund, providing care for coronavirus patients throughout UCSF’s hospitals, clinics, and research labs.
- The Silicon Valley Strong Fund, addressing the economic impact of the COVID-19 coronavirus pandemic on Silicon Valley residents, businesses and community-based organizations.
- Funds for key regions to be distributed by Xilinx regional leadership in support of local needs.
“Additionally, we are matching employee contributions to relief efforts.
“For our healthcare industry customers whose products are critical to fighting the pandemic, Xilinx is providing special assistance, prioritising product fulfilment and expediting shipments.
“I am profoundly proud and grateful of the Xilinx team and the extended Xilinx family of customers, partners, and vendors as we all work together to get through this extremely difficult time.”
Xilinx has been at the forefront of providing technology to organisations playing key roles in not only combatting the virus and those affected by it.
In January, Xilinx came to support of China’s largest medical equipment maker, Mindray, with thousands of Spartan-7 devices to power patient monitoring systems in Wuhan.
Currently, Xilinx is working to support some of the largest medical suppliers in the US to supply critical technology to test and treat COVID-19.